Related Experiment Video
Updated: Aug 28, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Stroke Prevention in Atrial Fibrillation
1Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Insights
Atrial fibrillation (AF) stroke prevention is advancing with novel anticoagulants and left atrial appendage closure. Digital health tools are improving AF detection, but optimal risk stratification for device-detected AF requires further study.
Area of Science:
- Cardiology
- Neurology
- Digital Health
Background:
- Atrial fibrillation (AF) significantly increases stroke and systemic embolism risk.
- Effective stroke prevention is crucial for managing AF patients.
Purpose of the Study:
- To review current strategies for stroke prevention in atrial fibrillation.
- To discuss recent advances in antithrombotic therapies and digital health for AF detection.
Main Methods:
- Literature review of recent studies on AF stroke prevention.
- Analysis of novel oral anticoagulants (NOACs), left atrial appendage (LAA) closure, and digital health devices.
Main Results:
- NOACs have largely replaced warfarin for AF stroke prevention.
- LAA closure is a viable alternative for patients who cannot use anticoagulation.
- Consumer-directed AF screening via digital devices is increasing.
Conclusions:
- Stroke prevention remains a priority in AF management.
- Further research is needed to determine the stroke risk associated with device-detected AF and the benefit of anticoagulation for short/infrequent episodes.
- Digital health plays a growing role in AF detection and guiding stroke prevention strategies.
Purpose Of Review:
Atrial fibrillation is associated with a significant increase in stroke and systemic embolism. This review explores the areas of stroke prevention.
Recent Findings:
In the last decade, NOAC has overtaken warfarin as the anticoagulant of choice for stroke prevention in AF. For patients unable to take anticoagulation, LAA closure has proven to be a valid option. The use of digital devices has led to widespread consumer-directed AF screening. It remains to be determined if all device detect AF pose the same amount of risk as recent studies have shown that short and infrequent episodes of AF may not benefit from anticoagulation. Stroke prevention is paramount in the management of AF. In this review we describe the risk factors contributing to stroke, recent advances in antithrombotic therapies, and the increasing role of digital health in guiding AF detection and stroke prevention.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coronary Artery Disease IV: Preventive Measures
Dysrhythmias VI: Management of Dysrhythmias
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

